FIG A1.
ANBL0032 immunotherapy treatment regimen. aIsotretinoin is given on days 11-24 during cycle 1. bIL-2, days 0-3: 3 MIU/m2 daily (continuous infusion); days 7-10: 4.5 MIU/m2 daily (continuous infusion). GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-2, interleukin-2.